JPRN-UMIN000002551
Completed
未知
Prospective examination of clinical efficacy of alendronate which is administrated prophylactically in glucocorticoid-induced osteoporosis - HASEB(Hyogo Association of Secondary Endocrine and Bone metabolism)Study 3
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine0 sites40 target enrollmentSeptember 27, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Woman who hopes for pregnancy 2\)Patient who has serious hepatopathy, renal damage, and cardiac disease 3\)Patient who has received administering medicine that influences bone metabolism Medicine made of patient protein assimilation steroid(Winstrol, Primobolan, and Miotoron, etc.), Calcitonin(Elcitonin, Calcitriol, and Salmotonin, etc.), Ipriflavone(osten), vitamin K2(Glakey), androgenic hormone (TESTINON etc.), and female hormone (PREMARIN etc.), Raloxifene(Evista). However, after taking the medicine is stopped for eight weeks, it is possible to register. Patient who has received administering bisphosphonate. However, after taking the bisphosphonate is stopped for six months, it is possible to register. 4\)Patient who judged it is improper to participation of physician in charge in clinical trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A clinical trial to study and compare the effect of aloe vera and turmeric in patients with oral lichen planus.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2019/08/020856Sarkate Priyadarshani Rustum30
Completed
Not Applicable
A prospective study on clinical efficacy of anti-allergic medical therapy and nitric oxide levels in patients with allergic rhinitis.allergic rhinitisJPRN-UMIN000016536Hiroshima University Hospital110
Active, not recruiting
Not Applicable
A Phase III Study of the Efficacy and Safety of Alzhemed™ as Add-on Therapy in Mild to Moderate Alzheimer's Disease Patients.EUCTR2004-003435-31-SEeurochem Inc.930
Active, not recruiting
Not Applicable
A Phase III Study of the Efficacy and Safety of Alzhemed™ as Add-on Therapy in Mild to Moderate Alzheimer's Disease Patients.EUCTR2004-003435-31-BEeurochem Inc.930
Active, not recruiting
Phase 1
A Phase III Study of the Efficacy and Safety of Alzhemed™ as Add-on Therapy in Mild to Moderate Alzheimer's Disease Patients.Alzheimer’s Disease (AD) is an irreversible, progressive neuro-degenartive disorder, characterized by gradual cognitive deficits associated with abnormal behaviour, personality changes, and which ultimately leads to dementia.Cerebral amyloid angiopathy (CAA) has also been found to be particularly common in Alzheimer patients.MedDRA version: 8.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseEUCTR2004-003435-31-GBeurochem Inc.930